The Indian Council of Medical Research (ICMR) has entered into an agreement to collaborate on vaccine research and development with international vaccine development organisation International Vaccine Institute (IVI)...
Gland Pharma investors weighing 74% stake sale to Fosun in alternative plan
The shareholders of Gland Pharma Ltd, including buyout firm KKR and Co., are considering selling a stake of up to 74% under the automatic approval route to China’s Fosun International after failing to secure government...
China’s Fosun, Shanghai Pharma say bid for stake in U.S. drugmaker Arbor
A unit of China’s Fosun Group and Shanghai Pharmaceuticals Holding Co are among bidders for a stake in U.S. speciality drugmaker Arbor Pharmaceuticals LLC, the companies said on Monday. The bids come as Chinese...
Aurobindo Pharma, Intas in race for Teva’s European assets
Aurobindo Pharma Ltd and Intas Pharmaceuticals Ltd are in the race to acquire part of the European assets of Israeli generic drugmaker Teva Pharmaceutical Industries Ltd in a deal that, if completed, could be the...
Intas eyes Teva’s oncology, women’s health divisions in Europe
Within a year of buying out Teva’s UK and Ireland assets and breaking into the top 20 generics players club, Intas Pharmaceuticals is on the prowl again for a larger piece of Teva’s existing operations in Europe...
Acorda Therapeutics investor calls for company to explore sale
A New York-based hedge fund that owns 17 percent of Acorda Therapeutics Inc (ACOR.O) on Monday called on the U.S. developer of drugs targeting neurological disorders to explore a sale, according to a regulatory filing...
MedPlus in talks to raise $200 million from General Atlantic, True North
Private equity funds General Atlantic (GA) and True North are in advanced talks to jointly invest around $200 million in MedPlus Health Services Pvt. Ltd, the second-largest pharmacy retail chain in India, according to...
CCEA yet to take up Gland Pharma deal with Fosun
The cabinet committee on economic affairs (CCEA) is yet to take a call on the Gland Pharma-Fosun deal, a government official told ET. The proposal was listed for CCEA’s consideration two weeks back but could not be...
India raises concerns around Chinese firm Fosun’s takeover of Gland: Source
India has privately raised objections to Chinese firm Shanghai Fosun Pharmaceutical Group’s proposed $1.3 billion takeover of Indian drugmaker Gland Pharma, a source familiar with the matter said on Monday. The...
Claris completes sale of global injectables biz to Baxter
Claris LifesciencesBSE -3.86 % has completed the sale of its global generic injectables business to US- based Baxter International Inc for USD 625 million. The company said it will now discuss with its advisors and...
U.S. FTC approves Baxter’s acquisition of Claris business with condition
Baxter International Inc (BAX.N) and Claris Lifesciences Ltd (CLAI.BO) have agreed to divest two types of pharmaceutical products to settle U.S. Federal Trade Commission charges that Baxter’s proposed acquisition...
Time for pharma to make acquisitions in US, says Sanjiv Kaul
Indian pharma exporters’ profit margins have shrunk following increased approvals for generic drugs in the US. While increasing competition has led to price erosion, consolidation of distribution channels in the US has...
